Phasix Breast Mesh Lawsuit [2026 Investigation]

Phasix Mesh is a fully resorbable synthetic surgical mesh made from poly-4-hydroxybutyrate, or P4HB.

BD describes it as a monofilament, macroporous mesh intended to provide general soft tissue support where weakness exists in plastic and reconstructive surgery or in procedures involving soft tissue repair, such as hernia or other fascial defects.

Its open-pore structure is designed to support tissue ingrowth and vascularization during healing.

Unlike a permanent implant, Phasix is intended to provide temporary support and then gradually degrade over approximately 12 to 18 months.

As the material resorbs, the mesh is replaced by the patient’s own tissue.

Is Phasix FDA-Cleared for Breast Reconstruction?

BD’s Instructions for Use (IFU) describe Phasix Mesh as a resorbable implant intended for soft-tissue reinforcement in plastic and reconstructive surgery and other soft-tissue repair procedures.

The IFU describes the device as a P4HB mesh designed to provide temporary support during healing before gradually resorbing over approximately 12 to 18 months.

FDA communications involving mesh and acellular dermal matrix (ADM) products have discussed product labeling, reconstruction outcomes, complication reporting, and published clinical data related to implant-based breast procedures.

Published medical literature and FDA records also reflect that mesh materials, including products such as Phasix, have been used in some implant-based breast reconstruction procedures and internal support techniques.

In litigation involving breast mesh products, regulatory communications, operative records, product labeling, complication history, and postoperative outcomes are often reviewed together when evaluating claims involving mesh-assisted breast procedures.

Phasix Mesh has been used in some implant-based breast reconstruction procedures, including surgeries performed after mastectomy.

Published medical literature discussing poly-4-hydroxybutyrate (P4HB) scaffold materials describes their use in breast reconstruction and other reconstructive breast procedures as part of soft-tissue reinforcement and implant-support techniques.

Breast reconstruction literature also describes Phasix as an internal support material used by some plastic surgeons to help reinforce surrounding tissue and support implant positioning during healing.

These publications generally describe the material as part of implant-based reconstruction approaches intended to provide temporary structural support while healing occurs and tissue adapts after surgery.

FDA records and published literature also contain reports involving the use of P4HB-based mesh materials in breast reconstruction procedures following mastectomy.

One MAUDE adverse-event report states that P4HB-based Phasix had been used off-label for breast reconstruction in women after mastectomy.

In breast mesh litigation, published literature, operative reports, adverse-event records, and product-identification documentation are often reviewed together when evaluating how a mesh product was used during reconstruction and what postoperative complications were later reported.

Postoperative complications have been reported following implant-based breast reconstruction, augmentation, revision surgery, and procedures involving mesh or scaffold materials used for internal support.

Reported complications can vary depending on the patient’s anatomy, tissue quality, implant placement, surgical technique, healing response, infection risk, and other medical or postoperative factors.

Published medical literature and litigation involving breast mesh products describe complications occurring in some implant-based reconstruction procedures where mesh or scaffold materials were used to reinforce tissue or support implants during healing.

Reported postoperative complications may include infection, fluid collections, wound-healing problems, chronic pain, capsular contracture, implant-position changes, cosmetic deformities, revision surgery, or implant removal.

Infection and Seroma Formation

Infection and fluid accumulation are among the most commonly reported postoperative complications following implant-based breast procedures involving mesh or scaffold materials.

In some cases, infections involving the implant pocket or surrounding tissue may require antibiotics, drainage procedures, washout surgery, implant exchange, or implant removal.

Reported complications may include:

• Infection and inflammatory reactions
• Seroma or fluid buildup
• Severe breast pain
• Wound breakdown and delayed healing
• Mesh migration or displacement
• Exposed mesh or tissue erosion
• Skin necrosis and surrounding tissue damage
• Implant failure or loss
• Need for revision surgery or mesh removal

Hematoma and Wound Healing Complications

Hematoma and postoperative bleeding are recognized complications following breast reconstruction and implant-based surgery and may interfere with healing in some patients.

Delayed wound healing, incision separation, compromised circulation, and tissue necrosis may also occur, particularly in patients with thin tissue coverage, infection, prior radiation exposure, or other healing-related risk factors.

Implant Malposition/Migration

Implant-position changes and asymmetry may occur when scar tissue, tissue weakness, postoperative healing changes, or shifting of implanted support material affects the reconstructed breast.

In some cases, patients later require revision procedures to address asymmetry, implant malposition, cosmetic deformities, or ongoing discomfort following reconstruction.

Capsular Contracture and Tissue Response

Capsular contracture occurs when scar tissue surrounding a breast implant tightens or hardens, potentially causing firmness, distortion, discomfort, or changes in breast appearance.

Some patients later undergo capsulectomy, implant exchange, or revision surgery to address these complications.

Mesh Exposure and Implant Loss

Mesh exposure or tissue erosion may occur when wound healing is compromised or surrounding tissue breaks down during recovery.

In more severe cases involving infection, tissue damage, or reconstructive complications, implant removal or staged reconstruction changes may become necessary.

Deformity and Revision Procedures

Some patients report contour irregularities, asymmetry, implant-position changes, rippling, or cosmetic deformities following implant-based reconstruction procedures involving mesh or scaffold materials.

Revision surgery may be recommended when complications, scar tissue changes, implant-position problems, or reconstructive changes significantly affect comfort, appearance, or implant stability.

Chronic Pain and Nerve Issues

Persistent pain following breast surgery has been discussed in published medical literature involving reconstruction patients, including some who underwent mesh-assisted procedures.

Patients may report burning sensations, numbness, hypersensitivity, tightness, or radiating pain involving the breast, chest wall, or surrounding tissue after surgery.

In some cases, scar tissue formation, inflammation, swelling, or nerve irritation may contribute to ongoing discomfort requiring medical treatment or revision surgery.

Treatment Options for Breast Mesh Complications

Treatment depends on the type and severity of the complication and whether the reconstruction can be preserved.

Less severe complications may be managed with antibiotics, drainage procedures, wound care, or close postoperative monitoring.

More serious complications may require washout surgery, debridement, implant exchange, mesh removal, staged reconstruction procedures, or implant removal depending on the patient’s condition and recovery course.

Some patients undergo multiple procedures over time when complications persist or reconstruction outcomes continue to change after surgery.

Breast mesh lawsuits involve allegations concerning postoperative complications following implant-based breast reconstruction, revision procedures, and internal support techniques in which mesh or scaffold materials were used.

These cases often focus on issues such as product labeling, complication reporting, informed consent, postoperative outcomes, revision surgery, and the medical treatment required after complications developed.

Mesh and acellular dermal matrix (ADM) products used in breast procedures include both synthetic materials and biologic materials derived from human or animal tissue.

Published medical literature has discussed how postoperative outcomes may vary depending on patient anatomy, tissue quality, implant placement, surgical technique, healing response, infection risk, radiation exposure, and the type of material used during reconstruction.

FDA communications involving mesh and ADM products have discussed reconstruction outcomes, complication reporting, and labeling considerations involving implant-based breast procedures.

Multiple manufacturers and product lines have been referenced in litigation involving mesh-assisted breast reconstruction and internal support procedures.

Breast mesh lawsuits involving products associated with BD and other manufacturers generally contain allegations concerning:

• Product labeling and warnings related to postoperative complications
• Reported outcomes involving infection, seroma formation, implant loss, chronic pain, wound-healing problems, or revision surgery
• The use of mesh or scaffold materials in implant-based breast reconstruction procedures
• Implant-position changes, scar tissue complications, cosmetic deformities, or reconstructive changes following surgery
• The medical treatment required after postoperative complications developed
• Product performance and reconstruction outcomes in specific clinical settings

Plaintiffs in these cases may assert legal theories involving failure-to-warn claims, product liability allegations, negligence-based claims, or other product-related allegations depending on the facts and medical evidence involved.

Manufacturers named in litigation dispute allegations that their products were defective, improperly marketed, or inadequately labeled.

A postoperative complication alone does not establish liability.

These cases are typically evaluated through operative reports, product-identification records, complication timelines, revision history, pathology findings, and other medical documentation relevant to the patient’s treatment course.

You may qualify to file a breast mesh lawsuit if you received an internal bra mesh implant during breast reconstruction, augmentation, or revision surgery and experienced serious complications or injuries that required surgery to fix.

This applies to procedures where mesh was used to reinforce the breast or support an implant and the outcome required more than routine recovery.

The patients being evaluated under these claims are usually those who underwent implant-based reconstruction after mastectomy, revision of a prior reconstruction, or cosmetic breast surgery where mesh was placed to hold implant position or strengthen the breast pocket.

The situations that fall within this group involve complications that required further medical or surgical treatment, including:

• Infection involving the mesh or implant, including abscess or persistent inflammation
• Seroma requiring drainage, aspiration, or repeat procedures
• Wound breakdown, delayed healing, or tissue necrosis
• Capsular contracture causing firmness, distortion, or pain
• Implant malposition linked to loss of internal support
• Mesh migration, exposure, or erosion through tissue
• Removal of the mesh or implant, or revision of the reconstruction

These claims are evaluated by product liability attorneys and medical experts who review whether the complication required corrective treatment such as drainage, operative intervention, removal of the mesh or implant, or repeat reconstruction.

They also examine how the mesh was used during the procedure and what information was provided before surgery, including whether the patient was told that the mesh was not specifically cleared or studied for use in breast procedures and the risks associated with that use.

Evidence in an Internal Bra Mesh Claim

If your situation involves the complications described above, the next step is establishing proof.

Medical records, imaging, and operative notes help establish a clear connection between the mesh and the complications you experienced.

Strong evidence is essential in a breast mesh lawsuit because it documents exactly which product was used and how your injuries developed over time.

These claims rely on medical, surgical, and supporting documentation, including the following:

• Medical records and imaging: Detailed records documenting complications such as infection, seroma, capsular contracture, or tissue necrosis, along with imaging showing fluid collections, implant malposition, or structural changes.
• Operative reports and surgical records: Records from the original procedure identifying the mesh used, how it was placed, and whether it was used to support the implant or breast pocket.
• Revision or removal surgery records: Operative notes and follow-up documentation showing corrective procedures such as mesh removal, debridement, capsulectomy, or implant exchange.
• Device identification records: Documentation identifying the specific mesh product, including manufacturer, material composition such as P4HB, and lot or catalog details.
• Pathology and laboratory findings: Clinical evidence of infection, inflammatory response, foreign body reaction, or tissue damage associated with the mesh.

Medical records, imaging, and pathology findings are then reviewed to document complications such as seroma, infection, implant malposition, or tissue damage and when those conditions developed after surgery.

Revision surgery records and physician findings are used to determine whether the complication required mesh removal, capsulectomy, or reconstruction revision, and whether those procedures were medically linked to mesh performance, placement, or integration within the breast tissue.

Potential Compensation in Internal Bra Mesh Lawsuits

Damages represent the physical, emotional, and financial losses a patient experiences because of mesh-related injuries.

In breast mesh claims, compensation is evaluated based on the full treatment course, including whether complications such as infection, seroma, capsular contracture, mesh displacement, or tissue necrosis required intervention like drainage, IV antibiotics, operative washout, mesh removal, or reconstruction revision.

The value of a claim depends on how the condition progressed after implantation, the number and type of corrective procedures performed, and whether the reconstruction outcome was altered, failed, or could not be restored.

Damages in a breast mesh lawsuit may include:

• Medical expenses: Includes hospital treatment, imaging, antibiotics, drainage of fluid collections, surgical washout, mesh removal, capsulectomy, implant exchange, and follow-up care across multiple procedures.
• Lost income: Covers time away from work during recovery, including repeated surgical interventions, extended healing periods, or complications requiring ongoing care.
• Reduced functional capacity: Reflects limitations in upper body movement, physical activity, or daily tasks following multiple surgeries or unresolved complications.
• Pain and physical complications: Encompasses persistent pain, infection, inflammatory response, implant malposition, or ongoing symptoms that require continued monitoring or treatment.
• Disfigurement or reconstruction outcome: Addresses permanent changes such as asymmetry, contour deformities, skin damage, or cases where reconstruction fails or cannot be restored despite revision.
• Emotional distress: Relates to the psychological impact of failed reconstruction, repeated procedures, prolonged recovery, or visible changes in appearance.
• Future medical care: Accounts for anticipated revision surgeries, delayed reconstruction, or long-term monitoring where complications continue.

Breast mesh cases involve a sequence of surgical decisions, product use, and medical outcomes that develop over time.

When a procedure leads to complications requiring additional treatment, revision surgery, or changes in reconstruction, the situation often extends beyond routine recovery and requires closer review of what was used during surgery and how the outcome progressed.

At that stage, evaluating whether the complication is linked to the mesh, its placement, or its performance is not a simple medical question.

It requires an experienced attorney with a background in medical device and product liability cases to review operative records, identify the mesh product used, and assess whether the course of treatment supports a claim.

TorHoerman Law has experience representing individuals in cases involving surgical mesh and other medical devices and is investigating breast mesh injury claims involving reconstruction and internal support procedures.

If you or a loved one have experienced serious complications after being implant based breast reconstruction using mesh, you may be eligible to file a breast mesh lawsuit.

Contact TorHoerman Law today for a free consultation.

Use the chat feature on this page to find out if you qualify for a breast mesh lawsuit.